ImmuniWeb® Discovery is a commercial external attack surface management solution by ImmuniWeb. Zerofox External Attack Surface Management is a commercial external attack surface management solution by ZeroFox. Features, integrations, deployment and the company behind each one, side by side.
ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web.
Discovers and manages internet-facing assets with vulnerability prioritization
See more solutions in this category, or build a security stack from your picks.
Common questions when comparing ImmuniWeb® Discovery vs Zerofox External Attack Surface Management for external attack surface management.
ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. Built by ImmuniWeb.
Zerofox External Attack Surface Management: Discovers and manages internet-facing assets with vulnerability prioritization. Built by ZeroFox.
The table above shows where their features, integrations, deployment and company size fit differ.
ImmuniWeb® Discovery is made by ImmuniWeb. Zerofox External Attack Surface Management is made by ZeroFox. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. ImmuniWeb® Discovery and Zerofox External Attack Surface Management are both External Attack Surface Management products, and both cover Dark Web Monitoring. Use the table above to see where features, deployment and company size fit differ.
Need the answer fast? Best Attack Surface Management Solutions for Business picks Palo Alto Networks Cortex Xpanse, Microsoft Defender EASM, Mandiant Attack Surface Management and 4 more.See the shortlist
